Kylie Fletcher

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Aortic Dissection

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kylie Fletcher, Saba Rehman, Rebecca Irlmeier, Fei Ye, Douglas B Johnson
Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma. The oncologist (2024)
Kylie Fletcher, Douglas B Johnson
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update. Journal for immunotherapy of cancer 12 (7) (2024)
Kylie Fletcher, Douglas B Johnson
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update. Journal for immunotherapy of cancer 12 (7) (2024)
Rachel S Goodman, Seungyeon Jung, Kylie Fletcher, Hannah Burnette, Ismail Mohyuddin, Rebecca Irlmeier, Fei Ye, Douglas B Johnson
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study. Cancers 16 (13) (2024)
Kylie Fletcher, Douglas B Johnson
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update. Journal for immunotherapy of cancer 12 (7) (2024)
Rachel S Goodman, Seungyeon Jung, Kylie Fletcher, Hannah Burnette, Ismail Mohyuddin, Rebecca Irlmeier, Fei Ye, Douglas B Johnson
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study. Cancers 16 (13) (2024)